06 Oct 2023 --- A Canadian armed forces veteran suffering from treatment-resistant depression (TRD) has been approved for macro-dose psilocybin treatment and assisted psychotherapy starting this month. The approval of the psychedelic was granted under the Health Canada Special Access Program (SAP) and is consistent with the Summit-90 clinical trial protocol.
